MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma.

by Sameer A Dhayat, Wolf Arif Mardin, Jochen Seggewiß, Anda Jana Ströse, Christiane Matuszcak, Richard Hummel, Norbert Senninger, Sören Torge Mees, Jörg Haier
Published 2015-01-01